335 related articles for article (PubMed ID: 30862734)
1. Aspirin-triggered proresolving mediators stimulate resolution in cancer.
Gilligan MM; Gartung A; Sulciner ML; Norris PC; Sukhatme VP; Bielenberg DR; Huang S; Kieran MW; Serhan CN; Panigrahy D
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6292-6297. PubMed ID: 30862734
[TBL] [Abstract][Full Text] [Related]
2. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
[TBL] [Abstract][Full Text] [Related]
3. Lipoxins and new lipid mediators in the resolution of inflammation.
Schwab JM; Serhan CN
Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
[TBL] [Abstract][Full Text] [Related]
4. Human milk proresolving mediators stimulate resolution of acute inflammation.
Arnardottir H; Orr SK; Dalli J; Serhan CN
Mucosal Immunol; 2016 May; 9(3):757-766. PubMed ID: 26462421
[TBL] [Abstract][Full Text] [Related]
5. Resolvins suppress tumor growth and enhance cancer therapy.
Sulciner ML; Serhan CN; Gilligan MM; Mudge DK; Chang J; Gartung A; Lehner KA; Bielenberg DR; Schmidt B; Dalli J; Greene ER; Gus-Brautbar Y; Piwowarski J; Mammoto T; Zurakowski D; Perretti M; Sukhatme VP; Kaipainen A; Kieran MW; Huang S; Panigrahy D
J Exp Med; 2018 Jan; 215(1):115-140. PubMed ID: 29191914
[TBL] [Abstract][Full Text] [Related]
6. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines.
Arnardottir HH; Dalli J; Colas RA; Shinohara M; Serhan CN
J Immunol; 2014 Oct; 193(8):4235-44. PubMed ID: 25217168
[TBL] [Abstract][Full Text] [Related]
7. Lipoxins: resolutionary road.
Maderna P; Godson C
Br J Pharmacol; 2009 Oct; 158(4):947-59. PubMed ID: 19785661
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and proresolving lipid mediators.
Serhan CN; Yacoubian S; Yang R
Annu Rev Pathol; 2008; 3():279-312. PubMed ID: 18233953
[TBL] [Abstract][Full Text] [Related]
9. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.
Mitchell S; Thomas G; Harvey K; Cottell D; Reville K; Berlasconi G; Petasis NA; Erwig L; Rees AJ; Savill J; Brady HR; Godson C
J Am Soc Nephrol; 2002 Oct; 13(10):2497-507. PubMed ID: 12239238
[TBL] [Abstract][Full Text] [Related]
10. Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer.
Janakiram NB; Rao CV
Curr Mol Med; 2009 Jun; 9(5):565-79. PubMed ID: 19601807
[TBL] [Abstract][Full Text] [Related]
11. Formation of lipoxins and resolvins in human leukocytes.
Kahnt AS; Schebb NH; Steinhilber D
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
[TBL] [Abstract][Full Text] [Related]
12. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
Serhan CN; Chiang N
ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
[TBL] [Abstract][Full Text] [Related]
13. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
Serhan CN; Chiang N
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S200-15. PubMed ID: 17965751
[TBL] [Abstract][Full Text] [Related]
14. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages.
Croasdell A; Thatcher TH; Kottmann RM; Colas RA; Dalli J; Serhan CN; Sime PJ; Phipps RP
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L888-901. PubMed ID: 26301452
[TBL] [Abstract][Full Text] [Related]
15. Identification of proresolving and inflammatory lipid mediators in human psoriasis.
Sorokin AV; Norris PC; English JT; Dey AK; Chaturvedi A; Baumer Y; Silverman J; Playford MP; Serhan CN; Mehta NN
J Clin Lipidol; 2018; 12(4):1047-1060. PubMed ID: 29730187
[TBL] [Abstract][Full Text] [Related]
16. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.
Fredman G; Serhan CN
Biochem J; 2011 Jul; 437(2):185-97. PubMed ID: 21711247
[TBL] [Abstract][Full Text] [Related]
17. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
[TBL] [Abstract][Full Text] [Related]
18. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.
Orr SK; Colas RA; Dalli J; Chiang N; Serhan CN
Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L904-11. PubMed ID: 25770181
[TBL] [Abstract][Full Text] [Related]
19. New perspectives on aspirin and the endogenous control of acute inflammatory resolution.
Morris T; Stables M; Gilroy DW
ScientificWorldJournal; 2006 Aug; 6():1048-65. PubMed ID: 16951898
[TBL] [Abstract][Full Text] [Related]
20. Cutting Edge: Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids.
Serhan CN; de la Rosa X; Jouvene CC
J Immunol; 2018 Dec; 201(11):3161-3165. PubMed ID: 30355784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
